Skip to main content
Isracann Biosciences Inc. logo

Isracann Biosciences Inc. — Investor Relations & Filings

Ticker · ISCNF ISIN · CA46501D1087 CSE Agriculture, forestry and fishing
Open in API
Filings indexed 102 across all filing types
Latest filing 2024-04-26 Board/Management Inform…
Country CA Canada
Listing CSE ISCNF

About Isracann Biosciences Inc.

www.isracann.com

Isracann Biosciences Inc. is a pure-play firm specializing in the cultivation, distribution, and commercialization of medical cannabis. The company's core operations are centered in Israel, where it develops advanced cultivation solutions targeting the domestic medical cannabis market. Isracann emphasizes a strategy focused on becoming a premier, low-cost producer, positioning its products for both local consumption and future European export opportunities. The firm also engages in medical research and explores opportunities related to natural health medicines.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Board/Management Information Classification · 100% confidence The document is a company announcement dated January 22, 2024, from Isracann Biosciences Inc. It reports resignations of several directors and officers effective immediately. The content focuses exclusively on changes in the company's board of directors and senior management. There are no financial statements, regulatory certifications, or references to reports or filings. The document is short (1372 characters) and clearly fits the category of management changes. Therefore, the appropriate classification is Board/Management Information (MANG).
2024-04-26 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a bi-weekly default status report issued by Isracann Biosciences Inc. It references a management cease trade order (MCTO) granted by the British Columbia Securities Commission due to the company's failure to file its unaudited interim financial statements for the period ended November 30, 2022. The document is an update on the default status and the company's efforts to file the required documents. It does not contain actual financial statements or detailed financial analysis but serves as a regulatory update on the company's filing status and compliance with NP 12-203 guidelines. The document is relatively short (4541 characters) and functions as a regulatory announcement rather than a full financial report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance updates that do not fit other specific categories.
2023-03-16 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from Isracann Biosciences providing a bi-weekly default status report related to a management cease trade order (MCTO) issued by the British Columbia Securities Commission (BCSC). It discusses the company's failure to file unaudited interim financial statements and related documents by a specified deadline, and the ongoing issuance of status reports while in default. The document does not contain actual financial statements or detailed financial analysis, nor is it a full report like an interim or annual report. It is an update on regulatory compliance status and default reporting. The document length is 3741 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance updates that do not fit other specific categories.
2023-03-03 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the closing of a private placement financing by Isracann Biosciences Inc. It details the issuance of units consisting of common shares and warrants, the price per unit, total gross proceeds, and the intended use of proceeds. There is no financial statement or detailed financial report included. The document is short (4020 characters) and focuses on a capital raising event. This fits the definition of a Capital/Financing Update (CAP) rather than a full financial report or regulatory filing. Therefore, the appropriate classification is CAP with high confidence.
2023-02-17 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a delay in filing the company's second quarter interim financial statements, including related management discussion and analysis and CEO/CFO certifications. It does not contain the actual interim financial statements or substantive financial data but rather explains the reason for the delay and the expected filing date. The document is short (4316 characters) and serves as an announcement about the status of the interim report filing rather than the report itself. According to the 'Menu vs Meal' rule, this type of document should be classified as a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Since it is a regulatory announcement about filing delay and management cease trade order, the best fit is Regulatory Filings (RNS).
2023-02-01 English
Material change report - English.pdf
Board/Management Information Classification · 100% confidence The document is a Form 51-102F3 Material Change Report, which announces a significant change in the company's management, specifically the appointment of an interim CEO. It is not a full annual or interim report, nor an earnings release or audit report. The content focuses on management change, which aligns with the Board/Management Information category. The document length is short and it is a direct announcement of a management change, not a report or presentation. Therefore, the appropriate classification is MANG (Board/Management Information).
2023-01-24 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.